Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes: Findings from the GUSTO-IIb study

European Heart Journal

Volumn 21, Issue 21, 2000, Pages 1750-1758

  McGuire, Darren K ^a,f   Emanuelsson, H ^b   Granger, C B ^a   Ohman, E Magnus ^a   Moliterno, D J ^c   White, H D ^d   Ardissino, D ^e   Box, J W ^a   Califf, R M ^a   Topol, E J ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LERNER RESEARCH INSTITUTE   (United States)

^d GREEN LANE HOSPITAL   (New Zealand)

^e UNIVERSITY OF PAVIA   (Italy)

^f DUKE UNIVERSITY   (United States)

Author keywords

Diabetes mellitus; Heparin; Hirudin; Myocardial infarction; Unstable angina

Indexed keywords

HEPARIN; HIRUDIN;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK; SMOKING; ST SEGMENT ELEVATION; STROKE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0033763161     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2317     Document Type: Article

References (34)

1. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
2. Cardiovascular complications of diabetes mellitus: What we know and what we need to know about their prevention
3. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction
4. Prognosis of acute myocardial infarction in diabetic and non-diabetic patients
5. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
6. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
7. Influence of diabetes on mortality in acute myocardial infarction data from the GISSI-2 study
8. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial
9. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes
10. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes
11. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
12. Diabetes and ischemic heart disease
13. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: Review of ocular hemorrhage incidence and location in the GUSTO-I trial
14. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
15. Effects of metoprolol on mortality and late infarction in patients with diabetes with suspected acute myocardial infarction. Retrospective data from two large studies
16. Timolol treatment after myocardial infarction in diabetic patients
17. Diabetic patients and beta-blockers after acute myocardial infarction
18. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study
19. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
20. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
21. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
22. Antihypertensive therapy in type 2 diabetes: Implications of the appropriate blood pressure control in diabetes (ABCD) trial
23. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
24. Comorbidity of hypertension and diabetes: The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET)
25. Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial
26. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease
27. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI)
28. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty
29. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease
30. Diabetes-induced alterations in platelet metabolism
31. Thromboxane biosynthesis and platelet function in type II diabetes mellitus
32. Diabetes mellitus, vascular disease and thrombosis
33. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
34. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina